The earlier,
the better.
Aqsens Health develops non-invasive screening and diagnostic tests for preventive healthcare with the focus on early detection of cancers, and gastroenterological and infectious diseases.
The company’s Enhanced-TRF method provides an exceptionally quick, accurate and affordable solution for the analysis of biological samples. This makes efficient, large-scale disease screening possible, leading to a healthier society. The earlier a disease is diagnosed, the better the patient’s prognosis.
Biological samples carry critical information about our daily life, health and its potential disorders.
Communicable diseases
Communicable diseases are diseases like the common cold that spread from person to person. When pathogens enter our body, saliva is the first line of defence, before our bodies' immune system starts to fight against the intruders.
All this leaves traces in our bodies that can be detected by studying biological samples, like saliva.
Non-communicable diseases
Noncommunicable diseases are chronic diseases that do not transfer from person to person. The root causes for noncommunicable diseases are not always clear, but they are often the result of a combination of environmental, behavioural and genetic factors.
However, diseases like cancer are typically more active at the cellular level than healthy cells and will therefore produce detectable changes in our metabolism and biological samples like saliva, urine or feces.
Affordable solutions to address challenges in global preventive health
We are looking forward to the opportunity to present Aqsens Health's novel screening products to the Bangladeshian market: the need for low cost, mobile and non-invasive screening method here is obvious and it could be one of the key elements in the renewal of our national healthcare System
Alamgir Kabir Khan CEO Meditek Systems Dhaka, Bangladesh
We are eagerly working with Aqsens Health and the local authorities to extend their operations to Mexico. The market potential and need for the type of solutions they can offer for screening diseases and conditions is huge, not to mention the impact it could have to the healthcare spending and lives of individuals.
Dr. Victor M. Larios, Director of the Smart Cities Innovation Center at the University of Guadalajara